Clinical Trial: A Phase II Clinical Study of Finolimab Combined with TP Neoadjuvant Therapy Followed by Response-Driven Treatment Stratification Strategy for Laryngeal Preservation in Locally Advanced Laryngeal/Hypopharyngeal Cancer (China)

China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II Clinical Study of Finolimab Combined with TP Neoadjuvant Therapy Followed by Response-Driven Treatment Stratification Strategy for Laryngeal Preservation in Locally Advanced Laryngeal/Hypopharyngeal Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130836

Registration Time: 2026/08/25

Type: Interventional study

Primary Sponsor: Sun Yat-Sen University Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=323173

Published by HT Digital Content Services with permission from Health Daily Digest....